Treatment of multidrug-resistant tuberculosis (MDR-TB) with modified shorter all-oral treatment regimen (mSTR) under operational research conditions in Belarus

A. Skrahina (Minsk, Belarus), N. Yatskevich (Minsk, Belarus), H. Hurevich (Minsk, Belarus), V. Grankov (Minsk, Belarus), D. Klimuk (Minsk, Belarus), V. Solodovnikova (Minsk, Belarus), D. Viatushka (Minsk, Belarus), A. Skrahin (MInsk, Belarus), E. Gurbanova (Tartu, Estonia), M. Dara (Copenhagen, Denmark)

Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis

Session: Multidrug-resistant tuberculosis
Session type: E-poster session
Number: 1591

Disease area: Respiratory infections

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Skrahina (Minsk, Belarus), N. Yatskevich (Minsk, Belarus), H. Hurevich (Minsk, Belarus), V. Grankov (Minsk, Belarus), D. Klimuk (Minsk, Belarus), V. Solodovnikova (Minsk, Belarus), D. Viatushka (Minsk, Belarus), A. Skrahin (MInsk, Belarus), E. Gurbanova (Tartu, Estonia), M. Dara (Copenhagen, Denmark). Treatment of multidrug-resistant tuberculosis (MDR-TB) with modified shorter all-oral treatment regimen (mSTR) under operational research conditions in Belarus. 1591

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.